Rachael Morris
King's College London
14 Papers
4 Citations
Rachael Morris is an academic researcher from King's College London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Editor's Choice - Systematic Review and Meta-Analysis of Sex Specific Differences in Adverse Events After Open and Endovascular Intact Abdominal Aortic Aneurysm Repair: Consistently Worse Outcomes for Women.
Anna Pouncey,Michael David,Rachael Morris,Pinar Ulug,Guy Martin,Colin Bicknell,Janet T. Powell +6 more
TL;DR: In this article, a systematic review, meta-analysis, and meta-regression of sex specific differences in 30 day mortality and complications conducted according to PRISMA guidance (procedure CRD42020176398) from 2000 to 2020 were included; with separate analyses for EVAR and OAR.
54
A Systematic Review of the Safety and Efficacy of Stenting of the Inferior Vena Cava.
TL;DR: A systematic review of the literature and meta-analysis to investigate the safety and efficacy of inferior vena cava stenting in all adult patient groups was carried out by as discussed by the authors , where the Medline and Embase databases were searched for studies reporting outcomes for safety and effectiveness of IVC stenting for any indication in series of 10 or more patients.
11
Quality of life outcomes for patients undergoing venous stenting for chronic deep venous disease.
Rachael Morris,Anna Louise Pouncey,Belen Quintana,Taha Khan,Alberto Smith,Prakash Saha,Stephen Black +6 more
TL;DR: In this paper, the authors evaluated change in venous disease-specific quality of life (QoL) after iliac vein stenting for chronic venous outflow obstruction at 6, 12, 24, and 36 months.
10
Medium-term outcomes after inferior vena cava reconstruction for acute and chronic deep vein thrombosis and retroperitoneal fibrosis.
Narayanan Thulasidasan,Rachael Morris,Iakovos Theodoulou,Karen Breen,Prakash Saha,Narayan Karunanithy,Stephen Black +6 more
TL;DR: In this article, the authors evaluated the technical and clinical outcomes after endovascular inferior vena cava (IVC) reconstruction in patients with nonmalignant obstruction, and the outcomes measured were the primary, primary-assisted, and secondary patency rates, reintervention rates, and symptomatic resolution.
5
Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy
TL;DR: Current evidence supports its use in the management of deep venous reconstruction, especially in occlusive post-thrombotic disease, and patients should be made aware of the paucity of long-term data and the need for monitoring within a dedicated surveillance program following stent placement.
3